uniQure (QURE) CEO Kapusta sells 35K shares after exercising options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
uniQure N.V. CEO and Managing Director Matthew C. Kapusta reported option exercises and share sales in Ordinary Shares. On June 24–25, 2026, he exercised stock options to acquire 32,844 shares at $31.71 per share and sold 35,412 shares in open-market transactions around $50 per share. The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on October 5, 2025. Following these transactions, he directly holds 519,227 Ordinary Shares.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 35,412 shares ($1,771,174)
Net Sell
6 txns
Insider
Kapusta Matthew C
Role
CEO, Managing Director
Sold
35,412 shs ($1.77M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 28,716 | $0.00 | -- |
| Exercise | Ordinary Shares | 28,716 | $31.71 | $911K |
| Sale | Ordinary Shares | 28,716 | $50.02 | $1.44M |
| Exercise | Stock Option (Right to Buy) | 4,128 | $0.00 | -- |
| Exercise | Ordinary Shares | 4,128 | $31.71 | $131K |
| Sale | Ordinary Shares | 6,696 | $50.00 | $335K |
Holdings After Transaction:
Stock Option (Right to Buy) — 45,862 shares (Direct, null);
Ordinary Shares — 547,943 shares (Direct, null)
Footnotes (1)
- The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.30. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Stock Option vested in full on January 25, 2023.
Key Figures
Shares sold: 35,412 shares
Sale prices: $50.00–$50.30/share
Options exercised: 32,844 shares
+4 more
7 metrics
Shares sold
35,412 shares
Ordinary Shares sold in open-market trades on June 24–25, 2026
Sale prices
$50.00–$50.30/share
Weighted-average sale range with a reported price of $50.02
Options exercised
32,844 shares
Ordinary Shares acquired via option exercises at $31.71/share
Option exercise price
$31.71/share
Conversion or exercise price for Stock Options exercised
Post-transaction holdings
519,227 shares
Ordinary Shares directly owned after reported transactions
10b5-1 plan adoption date
October 5, 2025
Date the CEO adopted the Rule 10b5-1 sales plan
Option vesting date
January 25, 2023
Date the Stock Option vested in full
Key Terms
Rule 10b5-1, weighted average price, Stock Option (Right to Buy), Ordinary Shares, +1 more
5 terms
Rule 10b5-1 regulatory
"intended to comply with Rule 10b5-1 under the Securities Exchange Act"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
What insider transactions did uniQure (QURE) CEO Matthew Kapusta report?
Matthew Kapusta reported option exercises and share sales. He exercised stock options for 32,844 Ordinary Shares at $31.71 per share and sold 35,412 Ordinary Shares in open-market trades around $50 per share over June 24–25, 2026.
What stock options did the uniQure (QURE) CEO exercise in this Form 4?
He exercised options covering 32,844 shares. These consisted of 28,716 shares and 4,128 shares underlying Stock Options with a conversion or exercise price of $31.71 per share, which had vested in full on January 25, 2023.
What does the weighted average price disclosure mean in this uniQure (QURE) Form 4?
The reported sale price is a weighted average. Shares were sold in multiple trades between $50.00 and $50.30 per share, and the insider notes willingness to provide the exact number of shares sold at each separate price within that range upon request.